Skip to main content

ADVERTISEMENT

prostate cancer

Conference Coverage
02/15/2021
Journal of Clinical Pathways
Conference Coverage
02/15/2021
Journal of Clinical Pathways
AUA, ASTRO, and SUO Release Consensus Guideline on Advanced Prostate Cancer
Guideline Updates
06/30/2020
The American Urological Association (AUA), American Society for Radiation Oncology (ASTRO), and Society of Urologic Oncology (SUO) released a new clinical practice guideline for the diagnosis and treatment of...
The American Urological Association (AUA), American Society for Radiation Oncology (ASTRO), and Society of Urologic Oncology (SUO) released a new clinical practice guideline for the diagnosis and treatment of...
The...
06/30/2020
Journal of Clinical Pathways
Consensus Recommendations for Germline Testing in Prostate Cancer
Guideline Updates
06/15/2020
A session entitled “Implementation of Germline Testing for Prostate Cancer” held at the Philadelphia Prostate Cancer Consensus Conference in 2019 provided novel recommendations for genetic testing. Germline testing...
A session entitled “Implementation of Germline Testing for Prostate Cancer” held at the Philadelphia Prostate Cancer Consensus Conference in 2019 provided novel recommendations for genetic testing. Germline testing...
A...
06/15/2020
Journal of Clinical Pathways
News
06/03/2020
Androgen deprivation therapy (ADT) should be considered a critical component of treatment for men with intermediate- and high-risk prostate cancer regardless of radiotherapy delivery method, according to new...
Androgen deprivation therapy (ADT) should be considered a critical component of treatment for men with intermediate- and high-risk prostate cancer regardless of radiotherapy delivery method, according to new...
...
06/03/2020
Journal of Clinical Pathways
News
05/30/2020
At the American Society of Clinical Oncology (ASCO) Annual Meeting (May 29-31, 2020), researchers from ERT—a global data and technology company that helps minimize risk in clinical trials—shed light on the...
At the American Society of Clinical Oncology (ASCO) Annual Meeting (May 29-31, 2020), researchers from ERT—a global data and technology company that helps minimize risk in clinical trials—shed light on the...
At the...
05/30/2020
Journal of Clinical Pathways
Interview
01/11/2019
JCP Editors
Prostate cancer is the second most common cancer among men in the United States, as well as the third leading cause of cancer-related death.1 More than 160,000 men are diagnosed with prostate cancer annually, and...
Prostate cancer is the second most common cancer among men in the United States, as well as the third leading cause of cancer-related death.1 More than 160,000 men are diagnosed with prostate cancer annually, and...
...
01/11/2019
Journal of Clinical Pathways